150 related articles for article (PubMed ID: 20956343)
21. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
Seya T; Hara T; Matsumoto M; Akedo H
J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
[TBL] [Abstract][Full Text] [Related]
22. Regulation of complement activity by vaccinia virus complement-control protein.
McKenzie R; Kotwal GJ; Moss B; Hammer CH; Frank MM
J Infect Dis; 1992 Dec; 166(6):1245-50. PubMed ID: 1431243
[TBL] [Abstract][Full Text] [Related]
23. C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement.
Seya T; Nagasawa S; Atkinson JP
J Immunol; 1990 Mar; 144(6):2312-20. PubMed ID: 1690242
[TBL] [Abstract][Full Text] [Related]
24. Human complement regulator expression by the normal female reproductive tract.
Oglesby TJ; Longwith JE; Huettner PC
Anat Rec; 1996 Sep; 246(1):78-86. PubMed ID: 8876826
[TBL] [Abstract][Full Text] [Related]
25. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
Mold C; Walter EI; Medof ME
J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
[TBL] [Abstract][Full Text] [Related]
26. Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity.
Adams EM; Brown MC; Nunge M; Krych M; Atkinson JP
J Immunol; 1991 Nov; 147(9):3005-11. PubMed ID: 1717583
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).
Rosengard AM; Alonso LC; Korb LC; Baldwin WM; Sanfilippo F; Turka LA; Ahearn JM
Mol Immunol; 1999 Jul; 36(10):685-97. PubMed ID: 10509819
[TBL] [Abstract][Full Text] [Related]
28. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation.
Liszewski MK; Leung MK; Hauhart R; Buller RM; Bertram P; Wang X; Rosengard AM; Kotwal GJ; Atkinson JP
J Immunol; 2006 Mar; 176(6):3725-34. PubMed ID: 16517741
[TBL] [Abstract][Full Text] [Related]
29. Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity.
Kotwal GJ
Protein Cell; 2010 Dec; 1(12):1084-92. PubMed ID: 21213103
[TBL] [Abstract][Full Text] [Related]
30. The structure of complement C3b provides insights into complement activation and regulation.
Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of the complement control protein homolog of herpesvirus saimiri: ARG-118 is critical for factor I cofactor activities.
Singh AK; Mullick J; Bernet J; Sahu A
J Biol Chem; 2006 Aug; 281(32):23119-28. PubMed ID: 16760474
[TBL] [Abstract][Full Text] [Related]
32. Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.
Kinoshita T; Medof ME; Nussenzweig V
J Immunol; 1986 May; 136(9):3390-5. PubMed ID: 2420889
[TBL] [Abstract][Full Text] [Related]
33. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
[TBL] [Abstract][Full Text] [Related]
34. Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement.
Liszewski MK; Atkinson JP
J Immunol; 1996 Jun; 156(11):4415-21. PubMed ID: 8666815
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins.
Gautam AK; Panse Y; Ghosh P; Reza MJ; Mullick J; Sahu A
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12794-9. PubMed ID: 26420870
[TBL] [Abstract][Full Text] [Related]
36. Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance.
Smith SA; Sreenivasan R; Krishnasamy G; Judge KW; Murthy KH; Arjunwadkar SJ; Pugh DR; Kotwal GJ
Biochim Biophys Acta; 2003 Aug; 1650(1-2):30-9. PubMed ID: 12922167
[TBL] [Abstract][Full Text] [Related]
37. Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.
Mark L; Proctor DG; Blackbourn DJ; Blom AM; Spiller OB
Immunology; 2008 Feb; 123(2):228-38. PubMed ID: 17764451
[TBL] [Abstract][Full Text] [Related]
38. Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).
Mullick J; Singh AK; Panse Y; Yadav V; Bernet J; Sahu A
J Virol; 2005 May; 79(9):5850-6. PubMed ID: 15827200
[TBL] [Abstract][Full Text] [Related]
39. Functional properties of membrane cofactor protein of complement.
Seya T; Atkinson JP
Biochem J; 1989 Dec; 264(2):581-8. PubMed ID: 2481448
[TBL] [Abstract][Full Text] [Related]
40. Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus.
Spiller OB; Blackbourn DJ; Mark L; Proctor DG; Blom AM
J Biol Chem; 2003 Mar; 278(11):9283-9. PubMed ID: 12645526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
